[1]
2024. Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Individual Patient Response from the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s310. DOI:https://doi.org/10.25251/skin.8.supp.310.